NIAID Clinical Trials Data Repository, AccessClinicalData@NIAID, is an NIAID cloud-based, secure data platform that enables sharing of and access to reports and data sets from NIAID COVID-19 and other sponsored clinical trials for the basic and clinical research community.
Biomedical and health data coupled with powerful advanced data analytical and statistical tools provide innovative opportunities to accelerate the development of new and improved therapeutic interventions and diagnostics, improved prevention strategies and disease surveillance, and implement new and improved design of clinical trials.
This NIAID research resource provides a foundation with potential to improve the health of people in the United States and around the world.
New Data Sets
Accessclinicaldata@NIAID has a new expanded data set for Adaptive COVID-19 Treatment Trials, ACTT-2 and new data set from Adaptive COVID-19 Treatment Trials, ACTT-3.
Main Area of Focus
Allow the research community access to clinical data sets to harness the power of data to generate new knowledge to understand, treat, and prevent infectious diseases such as COVID-19.
Data Management and Sharing Guidelines
NIAID provides guidance on data-management and -sharing practices to ensure NIAID’s research adheres to NIH policies to serve knowledge sharing, secondary use, and reproducibility of NIAID-funded research data as well as enable opportunities to develop a data science workforce.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19, New England Journal of Medicine, December 11, 2020
Remdesivir for the Treatment of Covid-19 — Final Report, New England Journal of Medicine, November 5, 2020